# Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation

> **NCT05251129** · NA · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Vasculopathy

## Interventions

- **DRUG:** Atorvastatin 80 Mg Oral Tablet
- **DRUG:** Pravastatin 40 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT05251129
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-01
- **Primary completion:** 2030-06
- **Final completion:** 2030-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never submitted. Study team instead conducted a retrospective study which did not qualify for registration.
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05251129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05251129, "Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05251129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*